Clazosentan Affects Temporal Profile of Endothelin-A Expression in Macro- and Microcirculation after Subarachnoid Hemorrhage.

IF 1.6 4区 医学 Q2 CLINICAL NEUROLOGY
Neurologia medico-chirurgica Pub Date : 2026-02-15 Epub Date: 2025-12-20 DOI:10.2176/jns-nmc.2025-0185
Yuyuan Zheng, Masahito Kawabori, Yoichiro Fujioka, Shuho Gotoh, Ryota Tatezawa, Takuma Ikeda, Taishi Honda, Yo Nakahara, Erika Yoshie, Zheng Li, Yusuke Ohba, Miki Fujimura
{"title":"Clazosentan Affects Temporal Profile of Endothelin-A Expression in Macro- and Microcirculation after Subarachnoid Hemorrhage.","authors":"Yuyuan Zheng, Masahito Kawabori, Yoichiro Fujioka, Shuho Gotoh, Ryota Tatezawa, Takuma Ikeda, Taishi Honda, Yo Nakahara, Erika Yoshie, Zheng Li, Yusuke Ohba, Miki Fujimura","doi":"10.2176/jns-nmc.2025-0185","DOIUrl":null,"url":null,"abstract":"<p><p>Subarachnoid hemorrhage is a life-threatening cerebrovascular event, and cerebral vasospasm remains a major cause of poor neurological outcomes. Clazosentan, an endothelin-A receptor antagonist, has been recently approved in Japan to reduce post-subarachnoid hemorrhage vasospasm; however, recurrent vasospasm after cessation of therapy has occasionally been reported, which underlying mechanisms remain unclear. Moreover, endothelin-A receptor is also expressed on pericytes; however, the effects of clazosentan on microvascular endothelin-A receptor remain unexplored. In this study, we employed a rat subarachnoid hemorrhage model to investigate the temporal dynamics of vasospasm and endothelin-A receptor expression in both large arteries and microvessels, and to evaluate the effects of clazosentan administration. Sprague-Dawley rats were assigned to naïve controls, subarachnoid hemorrhage with saline, or subarachnoid hemorrhage with continuous clazosentan administration for 7 days via osmotic pumps. Vasospasm was assessed by arterial wall thickness, and endothelin-A receptor expression was quantified using immunohistochemistry and immunofluorescence, including staining with α-SMA, CD31, and PDGF-β. Clazosentan significantly attenuated vasospasm in the middle and anterior cerebral arteries, and recurrent vasospasm was observed 3 days after cessation of clazosentan, coinciding with sustained upregulation of endothelin-A receptor in these vessels. In microvessels, pericyte density transiently decreased, peaking at a nadir on day 3 post-subarachnoid hemorrhage, while endothelin-A receptor expression on pericytes was highest at the same time point, and further elevated by clazosentan treatment. These findings indicate that clazosentan induces endothelin-A receptor upregulation in both macro- and microcirculation, potentially contributing to recurrent vasospasm after treatment, and highlight the critical role of pericytes in post-subarachnoid hemorrhage vascular regulation.</p>","PeriodicalId":19225,"journal":{"name":"Neurologia medico-chirurgica","volume":" ","pages":"90-98"},"PeriodicalIF":1.6000,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12975303/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia medico-chirurgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2176/jns-nmc.2025-0185","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Subarachnoid hemorrhage is a life-threatening cerebrovascular event, and cerebral vasospasm remains a major cause of poor neurological outcomes. Clazosentan, an endothelin-A receptor antagonist, has been recently approved in Japan to reduce post-subarachnoid hemorrhage vasospasm; however, recurrent vasospasm after cessation of therapy has occasionally been reported, which underlying mechanisms remain unclear. Moreover, endothelin-A receptor is also expressed on pericytes; however, the effects of clazosentan on microvascular endothelin-A receptor remain unexplored. In this study, we employed a rat subarachnoid hemorrhage model to investigate the temporal dynamics of vasospasm and endothelin-A receptor expression in both large arteries and microvessels, and to evaluate the effects of clazosentan administration. Sprague-Dawley rats were assigned to naïve controls, subarachnoid hemorrhage with saline, or subarachnoid hemorrhage with continuous clazosentan administration for 7 days via osmotic pumps. Vasospasm was assessed by arterial wall thickness, and endothelin-A receptor expression was quantified using immunohistochemistry and immunofluorescence, including staining with α-SMA, CD31, and PDGF-β. Clazosentan significantly attenuated vasospasm in the middle and anterior cerebral arteries, and recurrent vasospasm was observed 3 days after cessation of clazosentan, coinciding with sustained upregulation of endothelin-A receptor in these vessels. In microvessels, pericyte density transiently decreased, peaking at a nadir on day 3 post-subarachnoid hemorrhage, while endothelin-A receptor expression on pericytes was highest at the same time point, and further elevated by clazosentan treatment. These findings indicate that clazosentan induces endothelin-A receptor upregulation in both macro- and microcirculation, potentially contributing to recurrent vasospasm after treatment, and highlight the critical role of pericytes in post-subarachnoid hemorrhage vascular regulation.

克拉生坦对蛛网膜下腔出血后宏微循环内皮素a表达的影响。
蛛网膜下腔出血是危及生命的脑血管事件,脑血管痉挛仍然是神经预后不良的主要原因。Clazosentan是一种内皮素- a受体拮抗剂,最近在日本被批准用于减少蛛网膜下腔出血后血管痉挛;然而,停止治疗后复发性血管痉挛偶有报道,其潜在机制尚不清楚。内皮素a受体在周细胞上也有表达;然而,克拉生坦对微血管内皮素- a受体的影响尚不清楚。本研究采用大鼠蛛网膜下腔出血模型,研究了大鼠大动脉和微血管血管痉挛和内皮素a受体表达的时间动态,并评价了克拉生坦给药的效果。将Sprague-Dawley大鼠分为naïve对照组、生理盐水蛛网膜下腔出血组和通过渗透泵连续给药克拉生坦7天蛛网膜下腔出血组。通过动脉壁厚度评估血管痉挛,通过免疫组织化学和免疫荧光定量检测内皮素- a受体的表达,包括α-SMA、CD31和PDGF-β染色。克唑生坦可显著减轻大脑中、前动脉血管痉挛,停用克唑生坦3天后血管痉挛复发,与这些血管内皮素- a受体持续上调一致。在微血管中,周细胞密度短暂下降,在蛛网膜下腔出血后第3天达到最低点,而内皮素- a受体在同一时间点上的表达最高,并在克拉生坦治疗后进一步升高。这些发现表明,clazosentan诱导内皮素- a受体在大循环和微循环中上调,可能导致治疗后血管痉挛复发,并强调了周细胞在蛛网膜下腔出血后血管调节中的关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurologia medico-chirurgica
Neurologia medico-chirurgica 医学-临床神经学
CiteScore
3.70
自引率
10.50%
发文量
63
审稿时长
3-8 weeks
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书